Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1980 May;43(5):390–396. doi: 10.1136/jnnp.43.5.390

Motor neurone disease with elevated cerebrospinal fluid protein.

R J Guiloff, B McGregor, E Thompson, W Blackwood, E Paul
PMCID: PMC490564  PMID: 7420088

Abstract

The correlation between age and CSF protein in 38 patients with pathologically proven motor neurone disease was the reverse of that described for normal subjects by Tibbling et al in 1977. Eight had CSF protein ranging from 0.75 g/1 to 1.52 g/L. These patients were younger, but other clinical and gross and light microscopy pathological features were not significantly different from those with lower CSF protein. Transudation from serum may be only one of the mechanisms underlying this elevation in CSF protein.

Full text

PDF
390

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aimard G., Bady B., Boisson D., Trouillas P., Devic M. Sclérose latérale amyotrophique survenue avant 40 ans. Remarques à propos de 25 observations. Rev Neurol (Paris) 1976 Aug;132(8):563–566. [PubMed] [Google Scholar]
  2. BOKONJIC R., RENDERS J. ETUDE 'ELECTROPHOR'ETIQUE DE 400 LIQUIDES C'EPHALO-RACHIDIENS PATHOLOGIQUES. Acta Neurol Psychiatr Belg. 1964 Aug;64:769–776. [PubMed] [Google Scholar]
  3. Brain L., Croft P. B., Wilkinson M. Motor neurone disease as a manifestation of neoplasm (with a note on the course of classical motor neurone disease). Brain. 1965 Sep;88(3):479–500. doi: 10.1093/brain/88.3.479. [DOI] [PubMed] [Google Scholar]
  4. Brownell B., Oppenheimer D. R., Hughes J. T. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry. 1970 Jun;33(3):338–357. doi: 10.1136/jnnp.33.3.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CUMINGS J. N. Biochemical aspects. Proc R Soc Med. 1962 Dec;55:1023–1024. [PubMed] [Google Scholar]
  6. CUMINGS J. N. The diagnostic value of the examination of the cerebrospinal fluid. Postgrad Med J. 1952 Nov;28(325):587–591. doi: 10.1136/pgmj.28.325.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Castaigne P., Lhermitte F., Cambier J., Escourolle R., Le Bigot P. Etude neuropathologique de 62 observations de sclérose latérale amyotrophique. Discussion nosologique. Rev Neurol (Paris) 1972 Oct;127(4):401–414. [PubMed] [Google Scholar]
  8. GOA J. A micro biuret method for protein determination; determination of total protein in cerebrospinal fluid. Scand J Clin Lab Invest. 1953;5(3):218–222. doi: 10.3109/00365515309094189. [DOI] [PubMed] [Google Scholar]
  9. Gårde A., Kjellin K. G. Diagnostic significance of cereborspinal-fluid examinations in myelopathy. Acta Neurol Scand. 1971;47(5):555–568. doi: 10.1111/j.1600-0404.1971.tb07508.x. [DOI] [PubMed] [Google Scholar]
  10. Kjellin K. G., Stibler H. Isoelectric focusing and electrophoresis of cerebrospinal fluid proteins in muscular dystrophies and spinal muscular atrophies. J Neurol Sci. 1976 Jan;27(1):45–57. doi: 10.1016/0022-510x(76)90233-1. [DOI] [PubMed] [Google Scholar]
  11. LAWYER T., Jr, NETSKY M. G. Amyotrophic lateral sclerosis. AMA Arch Neurol Psychiatry. 1953 Feb;69(2):171–192. doi: 10.1001/archneurpsyc.1953.02320260029002. [DOI] [PubMed] [Google Scholar]
  12. MEULEMANS O. Determination of total protein in spinal fluid with sulphosalicylic acid and trichloroacetic acid. Clin Chim Acta. 1960 Sep;5:757–761. doi: 10.1016/0009-8981(60)90020-6. [DOI] [PubMed] [Google Scholar]
  13. Mulder D. W., Howard F. M., Jr Patient resistance and prognosis in amyotrophic lateral sclerosis. Mayo Clin Proc. 1976 Sep;51(9):537–541. [PubMed] [Google Scholar]
  14. Müller-Jensen A., Bernhardt W. Unsere Erfahrungen bei der myatrophischen Lateralsklerose. Nervenarzt. 1973 Mar;44(3):143–149. [PubMed] [Google Scholar]
  15. Osuntokun B. O., Adeuja A. O., Bademosi O. The prognosis of motor neuron disease in Nigerian africans. A prospective study of 92 patients. Brain. 1974 Jun;97(2):385–394. doi: 10.1093/brain/97.1.385. [DOI] [PubMed] [Google Scholar]
  16. Pennock C. A., Passant L. P., Bolton F. G. Estimation of cerebrospinal fluid protein. J Clin Pathol. 1968 Jul;21(4):518–520. doi: 10.1136/jcp.21.4.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. SARTESCHI P., FABIANI P. Limiti all'indagine elettroforetica su carta della crasi proteica ematoliquorale in malati neurologici e psichici. Rass Studi Psichiatr. 1956;45(6):1193–1228. [PubMed] [Google Scholar]
  18. Schliep G., Felgenhauer K. Serum-CSF protein gradients, the blood-GSF barrier and the local immune response. J Neurol. 1978 May 18;218(2):77–96. doi: 10.1007/BF02402169. [DOI] [PubMed] [Google Scholar]
  19. Tibbling G., Link H., Ohman S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest. 1977 Sep;37(5):385–390. doi: 10.1080/00365517709091496. [DOI] [PubMed] [Google Scholar]
  20. Wall D. W., Gelfand M. Motor neuron disease in Rhodesian Africans. Brain. 1972;95(3):517–520. doi: 10.1093/brain/95.3.517. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES